A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART) [0.03%]
复发难治型原发中枢神经系统淋巴瘤补救治疗的多中心随机II/III期临床研究(替拉布林):JCOG2314(ReSTART)
Kota Kawabata,Fumiharu Ohka,Ryuta Saito et al.
Kota Kawabata et al.
Primary central nervous system lymphoma (PCNSL) is an aggressive malignancy. Patients refractory to high-dose methotrexate-based induction therapy have an extremely poor prognosis. Although whole-brain radiotherapy (WBRT) is the standard sa...
Authors' reply to "Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint" [0.03%]
关于“重新考虑前列腺癌筛查:净生存率的局限性以及以总生存率为终点的首要地位”的作者回复
Rina Tanaka,Michel P Coleman,Masashi Matsuzaka et al.
Rina Tanaka et al.
Bayesian re-analysis of ERA223 and PEACE-3 temporal dynamics and bone protection in radium-223-treated metastatic castration-resistant prostate cancer [0.03%]
基于ERA223和PEACE-3的223Ra治疗转移性激素抵抗性前列腺癌的时间效应与骨保护的Bayesian再分析
Wei Chen,Soichiro Yoshida,Shugo Yajima et al.
Wei Chen et al.
Objective: To define the time course of fracture risk with radium-223 in combination with androgen receptor pathway inhibitor (ARPi) therapy and assess the clinical impact of concomitant bone-protective agent (BPA) use on...
Surgical de-escalation in early-stage cervical cancer: current evidence and future perspectives [0.03%]
早期宫颈癌的手术降级治疗:当前证据和未来展望
Atsushi Fusegi,Kyohei Nishikawa,Tsubasa Kon et al.
Atsushi Fusegi et al.
The surgical management of early-stage cervical cancer is undergoing a paradigm shift from a uniform radical approach to a risk-adapted de-escalation strategy. Improved oncologic outcomes have increased long-term survival, bringing attentio...
Implementation strategies for cancer rehabilitation in clinical practice: a Delphi study [0.03%]
癌症康复在临床实践中的实施策略:德尔菲研究
Nanako Hijikata,Nobuko Konishi,Noriatsu Tatematsu et al.
Nanako Hijikata et al.
Objective: The purpose of this study was to identify implementation strategies and determine priorities for establishing a seamless cancer rehabilitation delivery system based on consensus among multidisciplinary stakehol...
Correction to: Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter study [0.03%]
对阿帕鲁胺因不良事件停药后进阶前列腺癌切换雄激素受体信号传导抑制剂治疗的现实世界有效性:一项多中心研究的更正
Published Erratum
Japanese journal of clinical oncology. 2026 Jun 8:hyag094. DOI:10.1093/jjco/hyag094 2026
Characteristics and reasons for low-dose fentanyl patch use in opioid-naïve versus non-naïve patients with cancer pain [0.03%]
癌痛患者使用低剂量芬太尼透皮贴剂的特征和原因(阿片药物使用者与非使用者)
Shinya Kajiura,Shingo Chikaoka,Yuta Yagi et al.
Shinya Kajiura et al.
Background: Transdermal fentanyl is usually reserved for opioid-tolerant patients, but in Japan, a low-dose transdermal fentanyl patch (0.5 mg, delivering ~6 μg/h; Fentos tape®) has been approved for opioid-naïve cance...
Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer [0.03%]
既往接受过纳武单抗治疗对晚期胃癌患者紫杉醇联合雷莫卢单抗疗效的影响
Yusuke Miyajima,Takeshi Kawakami,Akifumi Notsu et al.
Yusuke Miyajima et al.
Background: Several studies have indicated that exposure to immune checkpoint inhibitors (ICIs) can enhance the efficacy of subsequent chemotherapy. Although combination chemotherapy with ICI has become a standard first-l...
Real-world outcomes of definitive chemoradiotherapy for bladder cancer: a multi-institutional retrospective study in Japan [0.03%]
日本多中心膀胱癌根治性化学放射治疗结局的回顾性研究
Daichi Sugahara,Keiko Nemoto Murofushi,Hideomi Yamashita et al.
Daichi Sugahara et al.
Objective: We aimed to evaluate real-world clinical outcomes and prognostic factors of definitive chemoradiotherapy (CRT) for bladder cancer in Japan. Met...
Age-standardized mortality-to-incidence ratio for testis cancer in the world [0.03%]
全球睾丸癌年龄标准化死亡率/发病比率分布
Tomohiro Matsuda,Sumiyo Okawa
Tomohiro Matsuda